Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VON TRAPP
NCT07587801Phase 2Not yet recruiting
- Sponsor
- Central Adelaide Local Health Network
- Start
- May 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in respiratory syncytial virus infection (RSV), influenza, sponsored by Central Adelaide Local Health Network. Planned start May 2026; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
respiratory syncytial virus infection (RSV)influenza
Beyond the preview
Go deeper on NCT07587801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587801.